Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...

This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing. IMforte [NCT05091567] is a Phase III, open-label, randomized trial evaluating the ...

Key Takeaways Wildfire smoke decreases lung cancer patients’ odds of survivalCalifornians with lung cancer had a 20% ...

A large study conducted in California highlights that exposure to wildfire smoke elevates the mortality risk among non-small ...

A California study finds that exposure to wildfire smoke significantly increases the risk of death among lung cancer patients ...

Breathing in wildfire pollution may make it harder for people with lung cancer to survive, according to a new study from UC ...

(Reuters) -Exposure to wildfire smoke may increase lung cancer patients' risk of dying from their disease, particularly among ...

Results from three trials continue to demonstrate the potential of DATROWAY® (datopotamab deruxtecan) in combination with ...

ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage ...

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. | ...

“Lung cancer is a disease where uncontrolled cell growth occurs in the lung leading to tumours,” explains Dr Jenny Messenger, ...